An advance for precision medicine
April 09, 2018
Discovery allows scientists to index thousands of cells simultaneously, a 40-fold increase from the current method.
Have an (artificial) heart
March 08, 2018
OHSU develops the first total artificial heart, designed to be a permanent replacement for a failing human heart.
Getting to Health Equity: When race no longer determines health
March 02, 2018
Harvard sociologist David R. Williams presented research on "the house that racism built," the first presentation in a new public lecture series.
First Oregonian receives artificial mitral heart valve without open-heart surgery
February 28, 2018
OHSU is the third institution nationally to perform transcatheter mitral valve replacement in new clinical trial.
OHSU, PNNL create joint research co-laboratory to advance precision medicine
February 14, 2018
Pacific Northwest National Laboratory and OHSU today announced a joint collaboration to improve patient care by focusing research on highly complex sets of biomedical data, and the tools to interpret them.
Activity monitors only effective when users set goals
January 08, 2018
Activity monitors alone may not motivate users to be more active, but trackers can have an impact when users set specific goals.
Cardiovascular experts encourage families to ‘talk turkey’ this Thanksgiving
November 23, 2017
A new online tool helps patients calculate their risk of heart disease based on information from their family tree.
OHSU Board of Directors announces presidential search committee, executive search firm
November 17, 2017
The OHSU Board of Directors has finalized the OHSU Presidential Search Committee and selected a nationally recognized executive search firm to support the recruitment process.
OHSU President Joe Robertson announces retirement: Oct. 31
October 19, 2017
OHSU has announced that Joe Robertson, M.D., M.B.A., will retire as president after nearly 40 years of service. Dr. Robertson said his decision is motivated by a desire to focus on his health and his family.
Drug improves heart's pumping efficiency
September 27, 2017
Review committee has no safety concerns following a Phase II trial of a drug used to treat hypertrophic cardiomyopathy.
